Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07058974 · ClinicalTrials.gov registry record · Phase 1
A Study of Exercise and Pharmacologic Intervention on Systemic Inflammation
A Phase 1 study of Smokers and Former Smokers, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT07058974 is a Phase 1 study of Smokers and Former Smokers that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 22 participants, below the 58-participant average among 3 other Smokers trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07058974, a Phase 1 study of Smokers and Former Smokers, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a study assessing the feasibility of performing an anti-aging intervention which is a combination of an exercise regimen, spermidine supplementation, and either rapamycin or lamivudine.
Conditions Studied
Interventions
- DRUG lamivudine
- DRUG rapamycin
- BEHAVIORAL Exercise Regimen
- DIETARY_SUPPLEMENT Spermidine
Study Locations (1)
New York
- Mount Sinai Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2025-08-25 |
| Est. Completion | 2026-07-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07058974
The ClinicalTrials.gov registry entry for NCT07058974 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 58-participant average among 3 other Smokers trials with a reported enrollment target (62% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Smokers appearing as the primary indexed condition, and to 4 interventions - of which lamivudine is the first listed.
NCT07058974 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT07058974 about?
NCT07058974 is a clinical study titled "A Study of Exercise and Pharmacologic Intervention on Systemic Inflammation". This is a study assessing the feasibility of performing an anti-aging intervention which is a combination of an exercise regimen, spermidine supplementation, and either rapamycin or lamivudine.
What is the current status of trial NCT07058974?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2025-08-25. Estimated completion is 2026-07-01.
What conditions does trial NCT07058974 study?
This clinical trial studies the following conditions: Smokers, Former Smokers.
What interventions are being tested in trial NCT07058974?
The interventions under investigation include: lamivudine (DRUG), rapamycin (DRUG), Exercise Regimen (BEHAVIORAL), Spermidine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07058974?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07058974 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smokers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Whole Body Periodic Acceleration on Airway Endothelial Function
COMPLETED · NA
-
Improving Medication Compliance and Smoking Cessation Treatment Outcomes for African American Smokers
COMPLETED · NA
-
Effect of Behavioral Training on Physiological Responses to Smoking Cues, Affect and Cortisol
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.